{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T21:33:58Z","timestamp":1783114438617,"version":"3.54.6"},"reference-count":92,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T00:00:00Z","timestamp":1774569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"vor","delay-in-days":4,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Misr University for Science & Technology"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Liver cancer remains a major global health challenge, with limited therapeutic options for advanced stages. Sorafenib, the standard first-line systemic therapy, provides only modest survival benefits and is frequently associated with drug resistance and adverse effects, necessitating the exploration of safer and more effective combination therapies. Frankincense, the olibanum gum resin from\n                    <jats:italic>Boswellia sacra<\/jats:italic>\n                    Fl\u00fcck.(Burseraceae), has long been used as a traditional medicinal remedy and is known to target multiple biological pathways, with diverse therapeutic activities. Owing to its reported multi-target anticancer, anti-inflammatory, and pro-apoptotic properties, frankincense represents a promising candidate for combination therapy aimed at enhancing sorafenib efficacy while potentially reducing required doses and associated toxicity. This study aimed to evaluate the cytotoxic activity of frankincense aqueous extract (FrAE) alone and in combination with sorafenib (SOR) against the hepatoblastoma cell line HepG2. Phytochemical analysis tentatively identified five diterpenoids and sixteen triterpenoids in FrAE. Both FrAE and SOR exhibited dose-dependent cytotoxicity, and their combination selectively enhanced cytotoxic effects, reducing the effective concentration of SOR and demonstrating strong synergism (CI\u2009=\u20090.298). Mechanistically, the combination induced integrated anticancer effects characterized by enhanced apoptosis and necrosis, activation of autophagic signaling, and marked inhibition of HepG2 cell migration, accompanied by cell cycle disruption across multiple phases. Molecular docking further supported these findings by demonstrating favorable binding of FrAE-derived terpenoids to key apoptotic (BCL-2, p53) and autophagic (mTOR, LC3C) regulators. Collectively, these findings suggest that the aqueous extract of frankincense enhances the anticancer efficacy of sorafenib, representing a promising adjuvant strategy for the management of liver cancer.\n                  <\/jats:p>","DOI":"10.1038\/s41598-026-42328-y","type":"journal-article","created":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T07:15:30Z","timestamp":1774595730000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Synergistic anticancer activity of frankincense aqueous extract with sorafenib in HepG2 cells and its UHPLC\u2013QTOF\u2013MS\/MS-based metabolomic profiling"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1809-8005","authenticated-orcid":false,"given":"Wesam","family":"Ragab","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamel","family":"Mahmoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seham Salah","family":"El-Din El-Hawary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osama M.","family":"Gomaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasha M.","family":"Allam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abeer","family":"S. Moawad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9683-4250","authenticated-orcid":false,"given":"Rabab","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,27]]},"reference":[{"key":"42328_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/nu14204252","volume":"14","author":"DB Kim","year":"2022","unstructured":"Kim, D. B., Lee, D. K., Cheon, C., Ribeiro, R. I. M. A. & Kim, B. Natural products for liver cancer treatment: From traditional medicine to modern drug discovery. Nutrients 14, 4252 (2022).","journal-title":"Nutrients"},{"key":"42328_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-02075-w","volume":"10","author":"J Zheng","year":"2025","unstructured":"Zheng, J. et al. Hepatocellular carcinoma: Signaling pathways and therapeutic advances. Signal Transduct. Target. Ther. 10, 35 (2025).","journal-title":"Signal Transduct. Target. Ther."},{"key":"42328_CR3","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.ejrad.2018.01.025","volume":"101","author":"C Ayuso","year":"2018","unstructured":"Ayuso, C. et al. Diagnosis and staging of hepatocellular carcinoma (HCC): Current guidelines. Eur. J. Radiol. 101, 72\u201381 (2018).","journal-title":"Eur. J. Radiol."},{"key":"42328_CR4","doi-asserted-by":"publisher","DOI":"10.4251\/wjgo.v17.i7.107815","volume":"17","author":"Q-J Liu","year":"2025","unstructured":"Liu, Q.-J. et al. Correlation of radiotherapy, targeted therapy, and immunotherapy with hepatocellular carcinoma recurrence. World J. Gastrointest. Oncol. 17, 107815 (2025).","journal-title":"World J. Gastrointest. Oncol."},{"key":"42328_CR5","doi-asserted-by":"publisher","DOI":"10.1007\/s12672-025-02773-z","volume":"16","author":"S Sadrinasab","year":"2025","unstructured":"Sadrinasab, S., Saket, S., Pourmohammadi, N., Khosravi, F. & Fakhr, M. S. Modern therapeutic approaches for hepatic tumors: Progress, limitations, and future directions. Discover Oncol. 16, 959 (2025).","journal-title":"Discover Oncol."},{"key":"42328_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/or.2021.7983","volume":"45","author":"G Yang","year":"2021","unstructured":"Yang, G., Xing, J., Aikemu, B., Sun, J. & Zheng, M. Kaempferol exhibits a synergistic effect with doxorubicin to inhibit proliferation, migration, and invasion of liver cancer. Oncol. Rep. 45, 1\u201310 (2021).","journal-title":"Oncol. Rep."},{"key":"42328_CR7","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/B978-0-12-800206-3.00012-4","volume-title":"Epigenetic Cancer Therapy","author":"S O\u2019Grady","year":"2015","unstructured":"O\u2019Grady, S. & Lawless, M. W. Liver cancer (Hepatocellular Carcinoma). In Epigenetic Cancer Therapy 269\u2013288 (Elsevier, 2015)."},{"key":"42328_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2022.120443","volume":"297","author":"YH Habiba","year":"2022","unstructured":"Habiba, Y. H., Omran, G. A., Helmy, M. W. & Houssen, M. E. Antitumor effects of rhamnazinon sorafenib-treated human hepatocellular carcinoma cell lines via modulation of VEGF signaling and PI3K\/NF-\u03baB p38\/caspase-3 axes cross talk. Life Sci. 297, 120443 (2022).","journal-title":"Life Sci."},{"key":"42328_CR9","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.semcancer.2019.08.014","volume":"69","author":"D Kashyap","year":"2021","unstructured":"Kashyap, D. et al. Natural product-based nanoformulations for cancer therapy: opportunities and challenges. Semin. Cancer Biol. 69, 5\u201323. https:\/\/doi.org\/10.1016\/j.semcancer.2019.08.014 (2021).","journal-title":"Semin. Cancer Biol."},{"key":"42328_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s44345-025-00016-w","volume":"2","author":"J-W Chen","year":"2025","unstructured":"Chen, J.-W., Chen, S. & Chen, G.-Q. Synergizing tyrosine kinase inhibitors with structurally diverse natural products: strategies to enhance efficacy and overcome drug resistance in liver cancer. Discover Molecules 2, 1\u201311 (2025).","journal-title":"Discover Molecules"},{"key":"42328_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.indcrop.2023.117106","volume":"203","author":"SA Khalifa","year":"2023","unstructured":"Khalifa, S. A. et al. Frankincense of boswellia sacra: traditional and modern applied uses, pharmacological activities, and clinical trials. Ind. Crops Prod. 203, 117106 (2023).","journal-title":"Ind. Crops Prod."},{"key":"42328_CR12","unstructured":"Efferth, T. & Oesch, F. Seminars in cancer biology. 39\u201357 (Elsevier)."},{"key":"42328_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.phyplu.2023.100517","volume":"4","author":"AM Elmoslemany","year":"2024","unstructured":"Elmoslemany, A. M., Elzallat, M., Abd-Elfatah, M. H., Mohammed, D. M. & Abd Elhady, E. E. Possible therapeutic effect of frankincense (gum olibanum) and myrrh (Commiphora myrrha) resins extracts on DEN\/CCL4 induced hepatocellular carcinoma in rats. Phytomedicine Plus 4, 100517 (2024).","journal-title":"Phytomedicine Plus"},{"key":"42328_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics11111591","volume":"11","author":"MBF Almutairi","year":"2022","unstructured":"Almutairi, M. B. F., Alrouji, M., Almuhanna, Y., Asad, M. & Joseph, B. In-vitro and in-vivo antibacterial effects of frankincense oil and its interaction with some antibiotics against multidrug-resistant pathogens. Antibiotics 11, 1591 (2022).","journal-title":"Antibiotics"},{"key":"42328_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.112669","volume":"147","author":"A Khan","year":"2022","unstructured":"Khan, A. et al. Anti-diabetic potential of \u03b2-boswellic acid and 11-keto-\u03b2-boswellic acid: Mechanistic insights from computational and biochemical approaches. Biomed. Pharmacother. 147, 112669 (2022).","journal-title":"Biomed. Pharmacother."},{"key":"42328_CR16","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.jchromb.2014.05.054","volume":"963","author":"Y Liu","year":"2014","unstructured":"Liu, Y. et al. Comprehensive identification of active triterpenoid metabolites in frankincense using a coupling strategy. J. Chromatogr. B 963, 90\u201398 (2014).","journal-title":"J. Chromatogr. B"},{"key":"42328_CR17","first-page":"501","volume":"10","author":"J-J Liu","year":"2002","unstructured":"Liu, J.-J., Nilsson, A., Oredsson, S., Badmaev, V. & Duan, R.-D. Keto-and acetyl-keto-boswellic acids inhibit proliferation and induce apoptosis in Hep G2 cells via a caspase-8 dependent pathway. Int. J. Mol. Med. 10, 501\u2013505 (2002).","journal-title":"Int. J. Mol. Med."},{"key":"42328_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1752-153X-7-153","volume":"7","author":"Y Zhang","year":"2013","unstructured":"Zhang, Y. et al. Triterpenoid resinous metabolites from the genus boswellia: pharmacological activities and potential species-identifying properties. Chem. Cent. J. 7, 1\u201316 (2013).","journal-title":"Chem. Cent. J."},{"key":"42328_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/genes15111460","volume":"15","author":"P \u0160tancl","year":"2024","unstructured":"\u0160tancl, P. et al. RNA-sequencing identification of genes supporting HepG2 as a model cell line for hepatocellular carcinoma or hepatocytes. Genes 15, 1460 (2024).","journal-title":"Genes"},{"key":"42328_CR20","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/978-3-030-21540-8_16","volume-title":"Hepatocellular Carcinoma: Translational Precision Medicine Approaches","author":"P Molina-S\u00e1nchez","year":"2019","unstructured":"Molina-S\u00e1nchez, P. & Lujambio, A. Experimental models for preclinical research in hepatocellular carcinoma. In Hepatocellular Carcinoma: Translational Precision Medicine Approaches 333\u2013358 (2019)."},{"key":"42328_CR21","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/3710821","volume":"2017","author":"D Hu","year":"2017","unstructured":"Hu, D. et al. A combined water extract of frankincense and myrrh alleviates neuropathic pain in mice via modulation of TRPV1. Neural Plast. 2017, 3710821 (2017).","journal-title":"Neural Plast."},{"key":"42328_CR22","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.3390\/molecules27031117","volume":"27","author":"ME Hussein","year":"2022","unstructured":"Hussein, M. E. et al. Identification of antibacterial metabolites from endophytic fungus aspergillus fumigatus, isolated from albizia lucidior leaves (fabaceae), utilizing metabolomic and molecular docking techniques. Molecules 27, 1117 (2022).","journal-title":"Molecules"},{"key":"42328_CR23","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/S0378-4347(01)00335-8","volume":"761","author":"MA Tawab","year":"2001","unstructured":"Tawab, M. A. et al. Development of a high-performance liquid chromatographic method for the determination of 11-keto-\u03b2-boswellic acid in human plasma. J. Chromatogr. B Biomed. Sci. Appl. 761, 221\u2013227 (2001).","journal-title":"J. Chromatogr. B Biomed. Sci. Appl."},{"key":"42328_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s43141-023-00473-1","volume":"21","author":"YM Elsaba","year":"2023","unstructured":"Elsaba, Y. M., El-Hennawi, H. M., Ibrahim, M. M. & Wehaidy, H. R. Production of a novel laccase from ceratorhiza hydrophila and assessing its potential in natural dye fixation and cytotoxicity against tumor cells. J. Genet. Eng. Biotechnol. 21, 14 (2023).","journal-title":"J. Genet. Eng. Biotechnol."},{"key":"42328_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.molstruc.2025.142203","volume":"1337","author":"BR Hussein","year":"2025","unstructured":"Hussein, B. R., El-Saghier, S. M., Allam, R. M., Mohamed, M. F. & Amer, A. A. Synthesis of the novel selena-3, 5, 8-triazaacenaphthylenes using p-TsOH as a catalyst and investigation of their anticancer activity. J. Mol. Struct. 1337, 142203 (2025).","journal-title":"J. Mol. Struct."},{"key":"42328_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e16411","author":"K Vichitsakul","year":"2023","unstructured":"Vichitsakul, K. et al. Anti-proliferation and induction of mitochondria-mediated apoptosis by Garcinia hanburyi resin in colorectal cancer cells. Heliyon https:\/\/doi.org\/10.1016\/j.heliyon.2023.e16411 (2023).","journal-title":"Heliyon"},{"key":"42328_CR27","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/0065-2571(84)90007-4","volume":"22","author":"T-C Chou","year":"1984","unstructured":"Chou, T.-C. & Talalay, P. Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Adv. Enzyme Regul. 22, 27\u201355 (1984).","journal-title":"Adv. Enzyme Regul."},{"key":"42328_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.phytochem.2025.114418","author":"AF Essa","year":"2025","unstructured":"Essa, A. F., Elghonemy, M. M., Taher, R. F., Allam, R. M. & Elshamy, A. I. Undescribed diterpenes from euphorbia mauritanica l. as modulators of the breast cancer resistance: mechanistic and in silico studies. Phytochemistry https:\/\/doi.org\/10.1016\/j.phytochem.2025.114418 (2025).","journal-title":"Phytochemistry"},{"key":"42328_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.toxrep.2024.101792","volume":"13","author":"BA Ali","year":"2024","unstructured":"Ali, B. A., Allam, R. M., Hasanin, M. S. & Hassabo, A. A. Biosynthesis of selenium nanoparticles as a potential therapeutic agent in breast cancer: G2\/M arrest and apoptosis induction. Toxicol. Rep. 13, 101792 (2024).","journal-title":"Toxicol. Rep."},{"key":"42328_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/s12906-023-04113-6","volume":"23","author":"K Shari","year":"2023","unstructured":"Shari, K. et al. Jatrophone: A cytotoxic macrocylic diterpene targeting PI3K\/AKT\/NF-\u03baB pathway, inducing apoptosis and autophagy in resistant breast cancer cells. BMC Complement. Med. Ther. 23, 293 (2023).","journal-title":"BMC Complement. Med. Ther."},{"key":"42328_CR31","doi-asserted-by":"publisher","first-page":"28563","DOI":"10.1021\/acsomega.3c02953","volume":"8","author":"OE Abdel-Sattar","year":"2023","unstructured":"Abdel-Sattar, O. E. et al. Hypophyllanthin and phyllanthin from Phyllanthus niruri synergize doxorubicin anticancer properties against resistant breast cancer cells. ACS Omega 8, 28563\u201328576 (2023).","journal-title":"ACS Omega"},{"key":"42328_CR32","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1007\/s00210-022-02269-5","volume":"395","author":"AA WalyEldeen","year":"2022","unstructured":"WalyEldeen, A. A. et al. [1, 2, 4] Triazolo [3, 4-a] isoquinoline chalcone derivative exhibits anticancer activity via induction of oxidative stress, DNA damage, and apoptosis in Ehrlich solid carcinoma-bearing mice. Naunyn Schmiedebergs Arch. Pharmacol. 395, 1225\u20131238 (2022).","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"42328_CR33","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.toxlet.2018.04.008","volume":"291","author":"RM Allam","year":"2018","unstructured":"Allam, R. M. et al. Fingolimod interrupts the cross talk between estrogen metabolism and sphingolipid metabolism within prostate cancer cells. Toxicol. Lett. 291, 77\u201385 (2018).","journal-title":"Toxicol. Lett."},{"key":"42328_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/s13321-019-0362-7","volume":"11","author":"EW Bell","year":"2019","unstructured":"Bell, E. W. & Zhang, Y. DockRMSD: An open-source tool for atom mapping and RMSD calculation of symmetric molecules through graph isomorphism. J. Cheminform. 11, 40 (2019).","journal-title":"J. Cheminform."},{"key":"42328_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.fbio.2023.102668","author":"HMM Elhaddad","year":"2023","unstructured":"Elhaddad, H. M. M. et al. Investigating the effect of extraction procedure on the anti-inflammatory metabolites of olibanum resin from different boswellia species through lc\u2013ms\/ms-based metabolomics. Food Biosci. https:\/\/doi.org\/10.1016\/j.fbio.2023.102668 (2023).","journal-title":"Food Biosci."},{"key":"42328_CR36","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.jpha.2019.09.007","volume":"9","author":"K Katragunta","year":"2019","unstructured":"Katragunta, K. et al. Estimation of boswellic acids in herbal formulations containing boswellia serrata extract and comprehensive characterization of secondary metabolites using UPLC-Q-Tof-MS(e). J. Pharm. Anal. 9, 414\u2013422. https:\/\/doi.org\/10.1016\/j.jpha.2019.09.007 (2019).","journal-title":"J. Pharm. Anal."},{"key":"42328_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.foodchem.2024.139968","volume":"456","author":"X Yu","year":"2024","unstructured":"Yu, X. et al. Distinguishing \u03b1\/\u03b2-linkages and linkage positions of disaccharides in galactooligosaccharides through mass fragmentation and liquid retention behaviour. Food Chem. 456, 139968 (2024).","journal-title":"Food Chem."},{"key":"42328_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2024.118224","volume":"330","author":"S-W Rao","year":"2024","unstructured":"Rao, S.-W. et al. Multi-omics and chemical profiling approaches to understand the material foundation and pharmacological mechanism of sophorae tonkinensis radix et rhizome-induced liver injury in mice. J. Ethnopharmacol. 330, 118224 (2024).","journal-title":"J. Ethnopharmacol."},{"key":"42328_CR39","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1016\/j.bbrc.2016.12.063","volume":"482","author":"M Mhlongo","year":"2017","unstructured":"Mhlongo, M. et al. Untargeted metabolomics analysis reveals dynamic changes in azelaic acid-and salicylic acid derivatives in LPS-treated nicotiana tabacum cells. Biochem. Biophys. Res. Commun. 482, 1498\u20131503 (2017).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"42328_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.phytochem.2023.113703","volume":"212","author":"N Zhang","year":"2023","unstructured":"Zhang, N. et al. Cembrane diterpenoids: chemistry and pharmacological activities. Phytochemistry 212, 113703 (2023).","journal-title":"Phytochemistry"},{"key":"42328_CR41","doi-asserted-by":"crossref","unstructured":"Yu JinQian, Y. J., Geng YanLing, G. Y., Zhao HongWei, Z. H. & Wang Xiao, W. X. Diterpenoids from the gum resin of Boswellia carterii and their biological activities. (2018).","DOI":"10.1016\/j.tet.2018.08.004"},{"key":"42328_CR42","doi-asserted-by":"publisher","first-page":"2074","DOI":"10.1021\/np400526b","volume":"76","author":"Y-G Wang","year":"2013","unstructured":"Wang, Y.-G. et al. Hepatoprotective prenylaromadendrane-type diterpenes from the gum resin of boswellia carterii. J. Nat. Prod. 76, 2074\u20132079 (2013).","journal-title":"J. Nat. Prod."},{"key":"42328_CR43","doi-asserted-by":"publisher","DOI":"10.1002\/rcm.9243","volume":"36","author":"J Uddin","year":"2022","unstructured":"Uddin, J., Muhsinah, A. B., Imran, M., Khan, M. N. & Musharraf, S. G. Structure\u2013fragmentation study of pentacyclic triterpenoids using electrospray ionization quadrupole time\u2010of\u2010flight tandem mass spectrometry (ESI\u2010QTOFMS\/MS). Rapid Commun. Mass Spectrom. 36, e9243 (2022).","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"42328_CR44","doi-asserted-by":"publisher","DOI":"10.1080\/10408347.2024.2312502","author":"D Kosolapov","year":"2024","unstructured":"Kosolapov, D. et al. Advances and challenges in the analysis of boswellic acids by separation methods. Crit. Rev. Anal. Chem. https:\/\/doi.org\/10.1080\/10408347.2024.2312502 (2024).","journal-title":"Crit. Rev. Anal. Chem."},{"key":"42328_CR45","doi-asserted-by":"publisher","DOI":"10.3390\/biom9010030","volume":"9","author":"N Yan","year":"2019","unstructured":"Yan, N. et al. A review on bioactivities of tobacco cembranoid diterpenes. Biomolecules 9, 30 (2019).","journal-title":"Biomolecules"},{"key":"42328_CR46","doi-asserted-by":"publisher","DOI":"10.3390\/biom9020045","volume":"9","author":"X-L Yuan","year":"2019","unstructured":"Yuan, X.-L. et al. Anti-tumor activity of cembranoid-type diterpenes isolated from nicotiana tabacum L. Biomolecules 9, 45 (2019).","journal-title":"Biomolecules"},{"key":"42328_CR47","doi-asserted-by":"publisher","first-page":"5400","DOI":"10.1080\/14786419.2021.1939331","volume":"36","author":"J-J Wang","year":"2022","unstructured":"Wang, J.-J. et al. Prenylaromadendrane-type diterpenoids from the gum resin of boswellia sacra flueck and their cytotoxic effects. Nat. Prod. Res. 36, 5400\u20135406 (2022).","journal-title":"Nat. Prod. Res."},{"key":"42328_CR48","doi-asserted-by":"crossref","unstructured":"Sun, X. et al. Frankincense from Boswellia: A review of species, traditional uses, phytochemistry, pharmacology and toxicology. Chinese Herbal Med. (2025).","DOI":"10.1016\/j.chmed.2025.09.007"},{"key":"42328_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.phytochem.2021.112897","volume":"191","author":"A Al-Harrasi","year":"2021","unstructured":"Al-Harrasi, A., Avula, S. K., Csuk, R. & Das, B. Cembranoids from Boswellia species. Phytochemistry 191, 112897 (2021).","journal-title":"Phytochemistry"},{"key":"42328_CR50","doi-asserted-by":"publisher","DOI":"10.3390\/molecules24112153","volume":"24","author":"M Schmiech","year":"2019","unstructured":"Schmiech, M. et al. Comparative analysis of pentacyclic triterpenic acid compositions in oleogum resins of different Boswellia species and their in vitro cytotoxicity against treatment-resistant human breast cancer cells. Molecules 24, 2153 (2019).","journal-title":"Molecules"},{"key":"42328_CR51","doi-asserted-by":"publisher","first-page":"118","DOI":"10.4103\/0973-1296.196308","volume":"13","author":"H Yang","year":"2017","unstructured":"Yang, H., Kim, H. W., Kim, Y. C. & Sung, S. H. Cytotoxic activities of naturally occurring oleanane-, ursane-, and lupane-type triterpenes on HepG2 and AGS cells. Pharmacogn. Mag. 13, 118 (2017).","journal-title":"Pharmacogn. Mag."},{"key":"42328_CR52","doi-asserted-by":"publisher","DOI":"10.1186\/1752-153X-7-153","volume":"7","author":"Y Zhang","year":"2013","unstructured":"Zhang, Y. et al. Triterpenoid resinous metabolites from the genus Boswellia: Pharmacological activities and potential species-identifying properties. Chem. Cent. J. 7, 153 (2013).","journal-title":"Chem. Cent. J."},{"key":"42328_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2022.106155","volume":"129","author":"B Zhang","year":"2022","unstructured":"Zhang, B. et al. Anti-proliferative tirucallane triterpenoids from gum resin of Boswellia sacra. Bioorg. Chem. 129, 106155 (2022).","journal-title":"Bioorg. Chem."},{"key":"42328_CR54","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1526206","volume":"15","author":"Z Ding","year":"2025","unstructured":"Ding, Z. et al. Hepatocellular carcinoma: Pathogenesis, molecular mechanisms, and treatment advances. Front. Oncol. 15, 1526206 (2025).","journal-title":"Front. Oncol."},{"key":"42328_CR55","doi-asserted-by":"publisher","first-page":"52","DOI":"10.17998\/jlc.2025.02.28","volume":"25","author":"HA Lee","year":"2025","unstructured":"Lee, H. A. Management of hepatocellular carcinoma in elderly and adolescent\/young adult populations. J. Liver Cancer 25, 52\u201366 (2025).","journal-title":"J. Liver Cancer"},{"key":"42328_CR56","doi-asserted-by":"publisher","DOI":"10.3390\/nu16111642","volume":"16","author":"J Guo","year":"2024","unstructured":"Guo, J. et al. Therapeutic effects of natural products on liver cancer and their potential mechanisms. Nutrients 16, 1642 (2024).","journal-title":"Nutrients"},{"key":"42328_CR57","doi-asserted-by":"publisher","first-page":"673","DOI":"10.3390\/pharmaceutics17050673","volume":"17","author":"G Muteeb","year":"2025","unstructured":"Muteeb, G., El-Morsy, M. T., Abo-Taleb, M. A., Mohamed, S. K. & Khafaga, D. S. Herbal medicine: Enhancing the anticancer potential of natural products in hepatocellular carcinoma therapy through advanced drug delivery systems. Pharmaceutics 17, 673 (2025).","journal-title":"Pharmaceutics"},{"key":"42328_CR58","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1403780","volume":"16","author":"RA Al-Balushi","year":"2025","unstructured":"Al-Balushi, R. A. et al. In vitro anticancer effects of frankincense and its nanoemulsions for enhanced cancer cell targeting. Front. Pharmacol. 16, 1403780 (2025).","journal-title":"Front. Pharmacol."},{"key":"42328_CR59","volume":"6","author":"MK Farahani","year":"2023","unstructured":"Farahani, M. K., Bitaraf, F. S., Atashi, A. & Jabbarpour, Z. Evaluation of anticancer effects of frankincense on breast cancer stem\u2010like cells. Cancer Rep. 6, e1693 (2023).","journal-title":"Cancer Rep."},{"key":"42328_CR60","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics17040426","volume":"17","author":"N Mohamed","year":"2025","unstructured":"Mohamed, N. et al. Anti-tumor potential of frankincense essential oil and its nano-formulation in breast cancer: An In Vivo and In Vitro Study. Pharmaceutics 17, 426 (2025).","journal-title":"Pharmaceutics"},{"key":"42328_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.imr.2023.100947","volume":"12","author":"MK Cho","year":"2023","unstructured":"Cho, M. K. et al. Frankincense ameliorates endometriosis via inducing apoptosis and reducing adhesion. Integr. Med. Res. 12, 100947 (2023).","journal-title":"Integr. Med. Res."},{"key":"42328_CR62","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1282239","volume":"14","author":"MA Jones","year":"2023","unstructured":"Jones, M. A., Borun, A. & Greensmith, D. J. Boswellia carterii oleoresin extracts induce caspase-mediated apoptosis and G1 cell cycle arrest in human leukaemia subtypes. Front. Pharmacol. 14, 1282239 (2023).","journal-title":"Front. Pharmacol."},{"key":"42328_CR63","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-02080-z","volume":"10","author":"I Pellarin","year":"2025","unstructured":"Pellarin, I. et al. Cyclin-dependent protein kinases and cell cycle regulation in biology and disease. Signal Transduct. Target. Ther. 10, 11 (2025).","journal-title":"Signal Transduct. Target. Ther."},{"key":"42328_CR64","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-025-02969-8","author":"H-Y Lin","year":"2025","unstructured":"Lin, H.-Y. et al. The epigenetic basis of hepatocellular carcinoma\u2013mechanisms and potential directions for biomarkers and therapeutics. Br. J. Cancer https:\/\/doi.org\/10.1038\/s41416-025-02969-8 (2025).","journal-title":"Br. J. Cancer"},{"key":"42328_CR65","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/j.ccell.2021.03.010","volume":"39","author":"JM Suski","year":"2021","unstructured":"Suski, J. M., Braun, M., Strmiska, V. & Sicinski, P. Targeting cell-cycle machinery in cancer. Cancer Cell 39, 759\u2013778 (2021).","journal-title":"Cancer Cell"},{"key":"42328_CR66","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1225694","volume":"13","author":"K Moloudi","year":"2023","unstructured":"Moloudi, K., Abrahamse, H. & George, B. P. Photodynamic therapy induced cell cycle arrest and cancer cell synchronization. Front. Oncol. 13, 1225694 (2023).","journal-title":"Front. Oncol."},{"key":"42328_CR67","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1002\/9781119432463.ch23","volume-title":"Apoptosis and beyond: the many ways cells die","author":"R De Souza","year":"2018","unstructured":"De Souza, R., Costa Ayub, L. & Yip, K. Mitotic catastrophe. In Apoptosis and beyond: the many ways cells die 475\u2013510 (2018)."},{"key":"42328_CR68","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.117598","volume":"180","author":"J Li","year":"2024","unstructured":"Li, J., Cheng, X., Huang, D. & Cui, R. The regulatory role of mitotic catastrophe in hepatocellular carcinoma drug resistance mechanisms and its therapeutic potential. Biomed. Pharmacother. 180, 117598 (2024).","journal-title":"Biomed. Pharmacother."},{"key":"42328_CR69","doi-asserted-by":"publisher","DOI":"10.3390\/cells10123327","volume":"10","author":"Z Wang","year":"2021","unstructured":"Wang, Z. Regulation of cell cycle progression by growth factor-induced cell signaling. Cells 10, 3327 (2021).","journal-title":"Cells"},{"key":"42328_CR70","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1472-6882-9-6","volume":"9","author":"MB Frank","year":"2009","unstructured":"Frank, M. B. et al. Frankincense oil derived from Boswellia carteri induces tumor cell specific cytotoxicity. BMC Complement. Altern. Med. 9, 1\u201311 (2009).","journal-title":"BMC Complement. Altern. Med."},{"key":"42328_CR71","doi-asserted-by":"publisher","DOI":"10.1080\/13510002.2025.2475696","volume":"30","author":"H-L Fan","year":"2025","unstructured":"Fan, H.-L. et al. Remimazolam induced cytotoxicity mediated through multiple stress pathways and acted synergistically with tyrosine kinase inhibitors in hepatocellular carcinoma. Redox Rep. 30, 2475696 (2025).","journal-title":"Redox Rep."},{"key":"42328_CR72","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s10142-025-01630-0","volume":"25","author":"L Ibrahim","year":"2025","unstructured":"Ibrahim, L. et al. Unveiling the therapeutic potential of targeting RRM2 in hepatocellular carcinoma: An integrated in silico and In vitro study. Funct. Integr. Genomics 25, 123 (2025).","journal-title":"Funct. Integr. Genomics"},{"key":"42328_CR73","doi-asserted-by":"publisher","DOI":"10.3390\/cells13110924","volume":"13","author":"O Franzese","year":"2024","unstructured":"Franzese, O., Ancona, P., Bianchi, N. & Aguiari, G. Apoptosis, a metabolic \u201chead-to-head\u201d between tumor and T cells: Implications for immunotherapy. Cells 13, 924 (2024).","journal-title":"Cells"},{"key":"42328_CR74","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-024-02116-x","volume":"10","author":"X Wu","year":"2024","unstructured":"Wu, X., Cao, J., Wan, X. & Du, S. Programmed cell death in hepatocellular carcinoma: Mechanisms and therapeutic prospects. Cell Death Discov. 10, 356 (2024).","journal-title":"Cell Death Discov."},{"key":"42328_CR75","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.18632\/oncotarget.27540","volume":"11","author":"FL Hakkim","year":"2020","unstructured":"Hakkim, F. L. et al. Correction: Frankincense essential oil suppresses melanoma cancer through down regulation of Bcl-2\/Bax cascade signaling and ameliorates heptotoxicity via phase I and II drug metabolizing enzymes. Oncotarget 11, 2259 (2020).","journal-title":"Oncotarget"},{"key":"42328_CR76","doi-asserted-by":"publisher","DOI":"10.1186\/s12645-022-00128-9","volume":"13","author":"AA Abd-Rabou","year":"2022","unstructured":"Abd-Rabou, A. A. & Edris, A. E. Frankincense essential oil nanoemulsion specifically induces lung cancer apoptosis and inhibits survival pathways. Cancer Nanotechnol. 13, 22 (2022).","journal-title":"Cancer Nanotechnol."},{"issue":"D","key":"42328_CR77","doi-asserted-by":"publisher","first-page":"281","DOI":"10.3889\/oamjms.2022.9979","volume":"10","author":"S Mostafa","year":"2022","unstructured":"Mostafa, S., El-Bolok, A. H. M., Fahmi, A. N. & Alaaeldin, E. An ex vivo apoptotic and cytotoxic effects of frankincense on oral squamous cell carcinoma cell line. Open Access Maced. J. Med. Sci. 10(D), 281\u2013290 (2022).","journal-title":"Open Access Maced. J. Med. Sci."},{"key":"42328_CR78","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-025-02135-w","volume":"23","author":"X Huang","year":"2025","unstructured":"Huang, X. et al. The inducible role of autophagy in cell death: emerging evidence and future perspectives. Cell Commun. Signal. 23, 151 (2025).","journal-title":"Cell Commun. Signal."},{"key":"42328_CR79","first-page":"1","volume":"25","author":"F Rahdan","year":"2025","unstructured":"Rahdan, F. et al. Autophagy-based therapy for hepatocellular carcinoma: From standard treatments to combination therapy, oncolytic virotherapy, and targeted nanomedicines. Clin. Exp. Med. 25, 1\u201323 (2025).","journal-title":"Clin. Exp. Med."},{"key":"42328_CR80","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2025.156404","author":"Z Wen","year":"2025","unstructured":"Wen, Z. et al. Formosanin C induces autophagy-mediated cell death in hepatocellular carcinoma through activating DUSP1\/AMPK\/ULK1\/Beclin1 signaling pathway. Phytomedicine https:\/\/doi.org\/10.1016\/j.phymed.2025.156404 (2025).","journal-title":"Phytomedicine"},{"key":"42328_CR81","doi-asserted-by":"publisher","DOI":"10.3390\/molecules30040890","volume":"30","author":"K Kozics","year":"2025","unstructured":"Kozics, K. et al. evaluation of bioactivity of essential oils: cytotoxic\/genotoxic effects on colorectal cancer cell lines, antibacterial activity, and survival of lactic acid bacteria. Molecules 30, 890 (2025).","journal-title":"Molecules"},{"key":"42328_CR82","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.cytogfr.2024.11.006","volume":"81","author":"Y Chen","year":"2025","unstructured":"Chen, Y. et al. LC3B: A microtubule-associated protein influences disease progression and prognosis. Cytokine Growth Factor Rev. 81, 16\u201326 (2025).","journal-title":"Cytokine Growth Factor Rev."},{"key":"42328_CR83","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10238-025-01698-9","volume":"25","author":"Y Jiang","year":"2025","unstructured":"Jiang, Y. et al. Navigating the complexities: Challenges and opportunities in conversion therapy for advanced hepatocellular carcinoma. Clin. Exp. Med. 25, 1\u201316 (2025).","journal-title":"Clin. Exp. Med."},{"key":"42328_CR84","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s42114-024-01133-9","volume":"8","author":"AS Desai","year":"2025","unstructured":"Desai, A. S. et al. Studying the wound healing property of biologically and chemically synthesized gold nanoparticles through scratch assay and neural network modeling. Adv. Compos. Hybrid Mater. 8, 1\u201319 (2025).","journal-title":"Adv. Compos. Hybrid Mater."},{"key":"42328_CR85","doi-asserted-by":"publisher","DOI":"10.3892\/mco.2023.2673","volume":"19","author":"X Lu","year":"2023","unstructured":"Lu, X., Mao, J., Wang, Y., Huang, Y. & Gu, M. Water extract of frankincense and myrrh inhibits liver cancer progression and epithelial\u2011mesenchymal transition through Wnt\/\u03b2\u2011catenin signaling. Mol. Clin. Oncol. 19, 77 (2023).","journal-title":"Mol. Clin. Oncol."},{"key":"42328_CR86","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1038\/cr.2008.77","volume":"18","author":"E Morselli","year":"2008","unstructured":"Morselli, E., Galluzzi, L. & Kroemer, G. Mechanisms of p53-mediated mitochondrial membrane permeabilization. Cell Res. 18, 708\u2013710 (2008).","journal-title":"Cell Res."},{"key":"42328_CR87","doi-asserted-by":"publisher","DOI":"10.3390\/biology11091325","volume":"11","author":"M Capuozzo","year":"2022","unstructured":"Capuozzo, M. et al. p53: From fundamental biology to clinical applications in cancer. Biology 11, 1325 (2022).","journal-title":"Biology"},{"key":"42328_CR88","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2025.189342","author":"PK Senapati","year":"2025","unstructured":"Senapati, P. K., Mahapatra, K. K., Singh, A. & Bhutia, S. K. mTOR inhibitors in targeting autophagy and autophagy-associated signaling for cancer cell death and therapy. Biochimica et Biophysica Acta (BBA)-Rev. Cancer https:\/\/doi.org\/10.1016\/j.bbcan.2025.189342 (2025).","journal-title":"Biochimica et Biophysica Acta (BBA)-Rev. Cancer"},{"key":"42328_CR89","doi-asserted-by":"publisher","first-page":"4053","DOI":"10.1016\/j.celrep.2019.11.063","volume":"29","author":"ES Bell","year":"2019","unstructured":"Bell, E. S. et al. LC3C-mediated autophagy selectively regulates the met RTK and HGF-stimulated migration and invasion. Cell Rep. 29, 4053-4068. e4056 (2019).","journal-title":"Cell Rep."},{"key":"42328_CR90","doi-asserted-by":"publisher","first-page":"480","DOI":"10.2174\/1570180819666220922103109","volume":"21","author":"MT Muhammed","year":"2024","unstructured":"Muhammed, M. T. & Aki-Yalcin, E. Molecular docking: Principles, advances, and its applications in drug discovery. Lett. Drug Des. Discov. 21, 480\u2013495 (2024).","journal-title":"Lett. Drug Des. Discov."},{"key":"42328_CR91","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1080\/1062936X.2023.2181392","volume":"34","author":"N Abd Emoniem","year":"2023","unstructured":"Abd Emoniem, N. et al. Turning down PI3K\/AKT\/mTOR signalling pathway by natural products: an in silico multi-target approach. SAR QSAR Environ. Res. 34, 163\u2013182 (2023).","journal-title":"SAR QSAR Environ. Res."},{"key":"42328_CR92","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-24229-y","volume":"12","author":"F Jamshidi-Adegani","year":"2022","unstructured":"Jamshidi-Adegani, F. et al. Comparative study of the cytotoxicity, apoptotic, and epigenetic effects of boswellic acid derivatives on breast cancer. Sci. Rep. 12, 19979 (2022).","journal-title":"Sci. Rep."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-42328-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-42328-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-42328-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T20:59:01Z","timestamp":1781643541000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-42328-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,27]]},"references-count":92,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["42328"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-42328-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,27]]},"assertion":[{"value":"18 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declaration"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10834"}}